6 min. Read

AstraZeneca DTx. Virgin Pulse takes on Omada.

Issue 034. Get E&O weekly. | Subscribe

Digital health research from Brian Dolan.

Welcome to E&O.

Last week's newsletter had a 56 percent open rate. Here's what's happening this week:

  • Healthcare investor and founder of NaviMed Capital, Bijan Salehizadeh, took VC-dabbling hospital executives behind the woodshed. In a well-liked Twitter thread, he explained why health systems' VC arms are shutting down. He noted (without naming names) that four high-profile non-profit health systems investment arms pulled the plug in recent months. (New York-Presbyterian, Inova and... who and who?) Tweets here.
  • One more Twitter thread worth a skim: Atul Gawande, who currently heads up Haven, tweeted some thoughts on the long-awaited, just-published RCT that revisits the concept of hot-spotting in population health. Gawande made the concept famous in a New Yorker article nine years ago. The RCT showed the

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
Facebook’s RCT for AI bot Zenny. More trials
7 min. Read
FDA de novo for Google smartphone thermometer.
6 min. Read
PDT-to-virtual-clinic trend continues. HCPCS tweaks.
8 min. Read
Mahana Tinnitus. New CPT hopefuls. Better cuts salaries
6 min. Read
CMS weighs HCPCS for Natural Cycles, Leva, and Tyto. Plus: Akili Q3 results.
8 min. Read
metaMe Health seeks buyer by year-end. CMS offers up digital therapeutics nothingburger
6 min. Read
PDT Pipeline changes. Kinsa shuts down. Trials
5 min. Read
CPT decisions. Trials: Big Health, Mahana and more
6 min. Read
Akili CEO steps down. Aetna rolls back some virtual care coverage
5 min. Read
Biogen cuts digital, MedRhythms, Apple. Pfizer on PDTs.
6 min. Read
  • First
  • Previous
  • 1 of 20
  • Next
  • Last